DAVID JAHN: Open Payments
NPI 1508802224 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125,003 in 273 payments from 18 companies in 2025. Trend: 2023 $82,638 · 2024 $110,254 · 2025 $125,003
Speaker / faculty: $92,530Honoraria: $14,983Travel & lodging: $7,349Food & beverage: $6,622Consulting: $3,520
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 65 | $49,323 |
| Vanda Pharmaceuticals Inc. | 38 | $20,126 |
| ABBVIE INC. | 37 | $19,007 |
| Janssen Pharmaceuticals, Inc | 23 | $17,888 |
| Axsome Therapeutics, Inc. | 27 | $16,900 |
| Teva Pharmaceuticals USA, Inc. | 13 | $411 |
| Neurocrine BioSciences, Inc. | 17 | $319 |
| Otsuka America Pharmaceutical, Inc. | 11 | $267 |
| E.R. Squibb & Sons, L.L.C. | 12 | $195 |
| Alkermes, Inc. | 9 | $147 |
Products named: CAPLYTA, FANAPT, VRAYLAR, INVEGA SUSTENNA, Auvelity, INGREZZA, REXULTI, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
